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Antioxidative and aldose reductase (AR)-inhibitory effects of a fermentation filtrate of Rubus coreanus
(FRC) were investigated using corneal/retinal homogenate and lens cytosol, respectively. Rat corneal/
retinal homogenate was treated with 50 µM FeCl3 in the presence of FRC (3.2-100 µg/mL) for 30 min at
37
oC, and thiobarbituric acid-reactive substances (TBARS) was quantified as a lipid peroxidation
parameter. FRC markedly suppressed the TBARS production in a concentration-dependent manner,
leading to 50% (IC50) and 100% (IC100) inhibitory concentrations of 20 and 95 µg/mL, respectively, which
was similar to the effect of butylated hydroxyanisole. Activity of AR from rat lens was assayed in the
presence of FRC (1-31.6 µg/mL) at 25
oC using glyceraldehyde as a substrate. FRC inhibited lens AR by
50% (IC50) and 90% (IC90) at approximately 2 and 31.6 µg/mL, respectively, comparable to the effect of
quercetin. The results indicate that ERC could be a promising candidate for the improvement of eye
injury and visual dysfunction of dry eye and diabetic patients.
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Dry eye comes from injuries of lacrimal functional unit
(lacrimal glands, cornea and eyelids and/or impairments of
sensory and motor nerves connecting the unit lacrimal
functional unit [1]. The disease is a complex symptom with
rapid breakdown of tear film, resulting in corneal damage
hindering eye ball movement and convenient seeing [2-4].
The major causes of dry eye are 1) environmental factors
such as reduced blinking frequency, aging, low humidity, and
antimuscarinic agents including atropine, 2) secondary effect
from immune dysfunction in Sjogren syndrome (or sicca
syndrome) and rheumatoid arthritis, and 3) excessive
evaporation of tears [5-8].
Diabetic retinopathy (DR), one of the most serious
complications of diabetes mellitus, frequently leads to blindness
[9,10]. Proliferative diabetic retinopathy (PDR) is the advanced
stage of DR characterized by new vessel formation
accompanied by fibrous tissue accumulation leading to vitreous
hemorrhage and subsequent tractional retinal detachment.
Among several biochemical changes, increased oxidative stress
[11-13] and accumulation of advanced glycation end products
(AGE) [14,15] may underlie the development of PDR. Since
excess accumulation of sorbitol produced from high glucose
by the catalytic activity of aldose reductase (AR) also contribute
to DR, some new drugs targeting these biochemical changes,
such as antioxidants [11-13], aldose reductase inhibitors [16]
and AGE inhibitors [17,18], have been studied as candidates
for the prevention of corneal injury and improvement of AR.
Rubus coreanus, which is well known as its Korean name
“Bokbunja”, has antiinflammatory, antifatigue, antioxidative
and male reproductive function-recovering properties [19-
22]. Since focal blood flow is one of the key factors of diabetic
foot ulcers [23], it is suggested that vasodilatating polyphenols
in Rubus coreanus, ginsenosides and vitamin C should be
beneficial for the improvement of visual function [22,24,25].
It is of interest to note that they are also strong antioxidants
[21,26], and especially ginseng components and vitamin C
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were found to inhibit AR [27,28]. Such results led us to
investigate the antioxidative and AR-inhibitory activities of
a fermentation filtrate of Rubus coreanus (FRC) in the eye
tissues, to confirm its potential effectiveness for the
improvement of visual function.
Ripe (reddish purple) fruits of the Rubus coreanus plant
were purchased from an organic farm at Hamyang, Korea,
in 2008. The fruits were minced, macerated, and adjusted
to 25-30% precipitates by adding purified water, to produce
a 20% starch content mixture. Into the homogenate, cultivated
Saccharomyces (strain HM 2104) was added up to 4% and
fermented at 45
oC and pH 5.5 for 30-40 h. The crude culture
precipitates were removed by centrifugation and microfiltration
(pore size, 0.05 µm), and the alcohol produced during
fermentation was fully removed in a vacuum evaporator.
Cornea and retina were obtained from the eye balls of
Sprague-Dawley (SD) rats by removing the lens and vitreous
body on an ice block. The tissues were homogenized in
19 volumes of 10 mM sodium phosphate-buffered saline (PBS,
pH7.4) to make a 5% homogenate at 4
oC. To induce lipid
peroxidation, the homogenate (225 µL) was mixed with 12.5
µL ferric chloride (FeCl3, final 50 µM) in the presence of
FRC (final 3.2-100 µg/mL) or butylated hydroxyanisole (BHA,
final 100 µM), and incubated for 30 min at 37
oC. The reaction
was then stopped by adding 250 µL sodium dodecyl sulphate
(SDS, 8.1% solution) and 500 µL 20% acetic acid (adjusted
to pH 3.5). After adding 250 µL 2-thiobarbituric acid (TBA,
0.75% solution), the mixture was boiled in a glass tube capped
with aluminum foil for 30 min. Samples were cooled on
ice, centrifuged at 13,000 g for 10 min, and absorbance of
the supernatant was read at 532 nm for the quantification
of thiobarbituric acid-reactive substances (TBARS).
Lenses of SD rats were vigorously homogenized in 9 volumes
of homogenization buffer (100 mM sodium phosphate, 0.5
mM phynylmethylsulfonylfluoride, 10 mM 2-mercaptoethanol,
pH7.0) to make a 5% homogenate at 4
oC. The homogenate
was centrifuged at 105,000 g for 60 min, and the supernatant
(cytosol) was used as AR enzyme source. Into 417.5 µL sodium
phosphate buffer (100 mM, pH7.0), 50 µL lens cytosol), 10
µL β-nicotinamide adenine dinucleotide phosphate (reduced
form of NADPH, final 0.16 mM) and FRC (final 1-31.6 µg/
mL), vitamin C (final 10-100 µg/mL) or quercetin (final 0.32-
31.6 µg/mL) were added, and mixed well. After adding 12.5
µL glyceraldehyde (10 mM in 2% NaCO3 in 0.1N NaOH,
pH 7.0), absorbance change at 340 nm was recorded for
5m i n  a t  2 5
oC.
Data were expressed as the mean±SEM. Statistical analysis
was performed using an analysis of variance (ANOVA) with
the aid of SPSS for Windows v.10.0 (Chicago, Illinois, USA).
A P value <0.05 was considered statistically significant.
Fifty µM FeCl3 significantly increased TBARS concentration,
lipid peroxidation products, by 74.7% (Table 1). Oxidative
stress is an important factor for damage of eye components
including cornea and retina in dry eye and diabetic patients
[4,12]. However, FRC treatment markedly attenuated the
TBARS production in a concentration-dependent manner
(40.7% at 10 µg/mL and 66.9% at 31.6 µg/mL), leading to
50% (IC50) and 100% (IC100) inhibitory concentrations of 20
µg/mL and 95 µg/mL, respectively, which was comparable
to the effect of a well-known antioxidant BHA. In fact,
antioxidative activities of Rubus coreanus and its ingredients
has been reported in other oxidation-inducing systems
(lipopolysaccharide or copper) in different tissues (liver and
lipoproteins) [21,26]. Notably, therefore, it was confirmed that
Rubus coreanus exerts antioxidative activity in diverse oxidative
systems including hepatic inflammation, atherosclerosis and
ocular injury.
FRC remarkably inhibited lens AR in a concentration-
dependent manner (37.4 and 67.7% at 1 and at 3.16 µg/
mL), leading to IC50 and IC90 of 2 and 31.6 µg/mL, respectively
(Table 2). Notably, vitamin C did not significantly inhibit lens
AR activity, in contrast to the strong inhibition of erythrocyte
AR [28]. Such a discrepancy in the inhibition of AR might
be due to the differences in tissues, implying that vitamin
C can exert negligible inhibitory effect on AR in the target
tissue (lens), rather than in blood erythrocytes with limited
access to eye tissues. In contrast, quercetin strongly inhibited
AR activity, leading to 50 and 90% inhibition at 0.4 and
20 µg/mL, respectively. The AR-inhibitory activity of quercetin
was higher than FRC. Unfortunately, however, it was reported
that quercetin has genotoxicity [29], implying that safety
assessment on quercetin is required for human trials. By
comparison, Rubus coreanus is being widely consumed as
diverse types of wine or juice in Korea. Although ginseng
Table 1. Antioxidative effects of a fermentation filtrate of Rubus
coreanus (FRC) and butylated hydroxyanisole (BHA) on FeCl3-
induced lipid peroxidation of cornea and retina
Treatment Concentration 
(µg/mL) TBARS (nM) % of control
Vehicle - 1.58±0.92 100.0±7.7
FeCl3 alone (50 µM) 2.76±0.87 174.7±9.2*
FRC 3.2 2.55±0.60 161.4±5.5
10 2.28±0.57 144.3±8.2
#
31.6 1.97±0.54 124.7±5.8
#
100 1.54±0.47 097.5±5.4
#
BHA 100 1.61±0.41 101.9±6.4
#
TBARS: thiobarbituric acid-reactive substances. *Significantly
different from vehicle control (P<0.05). 
#Significantly different from
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was demonstrated to inhibit lens AR [27], FRC was superior
to ginseng extract in our study (data not shown).
Taken together, our results demonstrated that FRC exhibits
strong antioxidative and AR-inhibitory activities in eye
components, in addition to its vasodilatating effect. Although
the analysis of active ingredients remains to be clarified, it
is suggested that FRC could be a promising candidate for
the improvement of eye injury and visual dysfunction of dry
eye and diabetic patients.
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